Life sciences GxP specialist joins forces with TICC player
Deal Flash
Pentahold, an independent Belgian private equity firm, and the founders of Advipro have sold the company to Normec.
Founded in 2003, Advipro is a leading Belgium-based engineering and consulting service provider focused on good practice quality guidelines and regulations (GxP) in the life sciences industry. The company has acquired expertise across the entire life sciences value chain, from research and clinical operations to manufacturing and patient care.
Normec is a rapidly growing player in western Europe in the field of testing, inspection, certification and compliance (TICC. It is a perfect match for Advipro to enable it to realize its goal of becoming the international reference GxP partner to the life sciences industry.
We chose to work with Oaklins because of its demonstrated sector expertise, international reach and experienced local deal team. They worked with a very hands-on approach and combined this with strong involvement from senior deal team members, thereby also allowing the Advipro management team to focus on the day-to-day business as much as possible throughout the process. Oaklins’ international reach and positioning of the asset were instrumental to the success of this transaction.GEERT VANDERSTAPPEN, PARTNER, PENTAHOLD, BELGIUM
Oaklins assists in finding the right partner
Oaklins’ team in Belgium acted as the exclusive M&A advisor to the shareholders of Advipro, including the majority shareholder Pentahold, an independent Belgian private equity firm, and its founders. Oaklins members abroad contacted potential candidates and the business support services team in the Netherlands introduced the final buyer. Leveraging its deep expertise, a comprehensive preparation stage enabled the Oaklins team to position Advipro as a trusted, specialized GxP engineering and consulting services provider with highly differentiated customer propositions.
Talk to our advisors
Director
View profile
Partner
View profile
Read more about the transaction, market trends, deal drivers and M&A valuation aspects
